Biopharmaceutical study of the hepatobiliary transport of drugs. VI. Inhibition of active biliary excretion of organic cations by retrograde infusion.
D000818:Animals; D001646:Bile / Q000187:drug effects / Q000378:metabolism*; D007202:Indicators and Reagents / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D008297:Male; D011342:Procainamide / Q000031:analogs & derivatives / Q000378:metabolism; D011803:Quinine / Q000378:metabolism; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology
D007202:Indicators and Reagents; D013501:Surface-Active Agents; D011803:Quinine; D011342:Procainamide